ArticleOncology letters2025

Role of ELP6 in tumour progression and impact on ERK1/2 signalling pathway inhibitors in skin cutaneous melanoma.

Ying Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.